Current pharmacology: flecainide
Lambrecht, G.
Medizinische Monatsschrift für Pharmazeuten 6(5): 129-130
1983
ISSN/ISBN: 0342-9601 PMID: 6855691 Document Number: 197618
Document emailed within 1 workday
Related Documents
Nitsch, J.; Köhler, U.; Neyses, L.; Lüderitz, B. 1988: Concentrations of amiodarone and flecainide in plasma and saliva--indications for the active transport of flecainide Zeitschrift für Kardiologie 77(2): 99-102De Schaepdryver, A.F. 1992: Clinical pharmacology: current status and perspectives Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 54(1): 7-26
Raevskiĭ, K.S. 1982: Neurochemical pharmacology: current problems and prospects Vestnik Akademii Meditsinskikh Nauk SSSR 5: 64-69
Persico, L. 1970: Current data on the pharmacology and therapeutical use of digitalis Il Policlinico. Sezione Pratica 77(49): 1587-1602
Ramírez, A.; García-Rubio, S. 2003: Current progress in the chemistry and pharmacology of akuammiline alkaloids Current Medicinal Chemistry 10(18): 1891-1915
Duchêne-Marullaz, P. 1977: Pharmacology, clinical pharmacology and therapeutic effects of Royat's thermal gas Semaine des Hopitaux. Therapeutique 53(7-8): 361-362
Bramann, H.U.; Bender, F.; Jachmann, H.; Grosse-Heitmeyer, W. 1984: Long-term therapy with flecainide Zeitschrift für Kardiologie 73(11): 724-731
Leclercq, J.F. 1985: New antiarrhythmia agents: propafenone and flecainide Presse Medicale 14(12): 685-689
Frabetti, F.; Dattola, L.; Bellodi, G.; Padovani, F. 1988: Severe proarrhythmic effects of flecainide La Clinica Terapeutica 127(1): 43-47
Paperini, L.; Davini, A.; Lattanzi, F.; Topi, A.; Reisenhofer, B.; Squarcini, G.; Paci, A.; Topi, P.L. 1995: Propafenone and flecainide in the therapy of ventricular arrhythmias Minerva Cardioangiologica 43(10): 449-457
Mletzko, R.; Jung, W.; Manz, M.; Kamradt, T.; Vogel, F.; Lüderitz, B. 1989: Arrhythmogenic effect of flecainide--treatment with I.v. magnesium Zeitschrift für Kardiologie 78(9): 602-606
Seipel, L.; Abendroth, R.R.; Breithardt, G. 1981: Electrophysiological effects of the new antiarrhythmic drug flecainide (R 818) in man Zeitschrift für Kardiologie 70(7): 524-529
McQuinn, R.L.; Quarfoth, G.J.; Johnson, J.D.; Banitt, E.H.; Pathre, S.V.; Chang, S.F.; Ober, R.E.; Conard, G.J. 1984: Biotransformation and elimination of 14C-flecainide acetate in humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 12(4): 414-420
Jähnchen, E. 1991: Interactions between digitoxin, flecainide and prajmalium bitartrate? Deutsche Medizinische Wochenschrift 116(26): 1035-1036
De Micheli, A.; Medrano, G.A.; Casanova, J.M. 1995: The action of intravenous flecainide in experimental ventricular arrhythmias Archivos del Instituto de Cardiologia de Mexico 65(5): 403-412
Senior, S.; Baessler, C.; Monzo, M. 1988: Flecainide acetate: critical care administration guidelines Heart and Lung: the Journal of Critical Care 17(1): 76-80
Frandsen, F.; Pless, P.; Mickley, H.; Møller, M. 1990: Antiarrhythmic treatment with flecainide (Tambocor). Clinical experience from 107 patients Acta Cardiologica 45(5): 351-357
Sihm, I.; Hansen, F.A.; Rasmussen, J.; Pedersen, A.K.; Thygesen, K. 1990: Flecainide acetate in atrial flutter and fibrillation. The arrhythmogenic effects European Heart Journal 11(2): 145-148
Vyas, B. 2001: European Association of Clinical Pharmacology and Therapeutics--Fifth Congress. Clinical pharmacology: from molecule to society--bridging the gap via Man IDrugs: the investigational drugs journal 4(10): 1133-1137
Garre, L.; Alvarez, A.; Cianciulli, T.; Quiroga, J.; Califano, J.; Mautner, B. 1989: Evaluation of the anti-arrhythmia effect of intravenous flecainide in supraventricular tachyarrhythmias Archivos del Instituto de Cardiologia de Mexico 59(3): 241-244